Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Enerpac Tool
EPAC
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 44.85%150.09M | -1.75%34.25M | 114.75%60.06M | 55.26%30.98M | 19.06%24.8M | 39.60%103.61M | 59.69%34.86M | 10.40%27.97M | 49.95%19.95M | 51.45%20.83M |
Net income from continuing operations | 91.19%-10.35M | 94.90%-3.96M | 149.58%3.22M | 20.51%-4.24M | 80.79%-5.37M | -1,443.32%-117.42M | -851.30%-77.67M | -220.70%-6.48M | -294.23%-5.33M | -316.76%-27.93M |
Operating gains losses | -231.01%-13.14M | --0 | ---- | ---- | ---- | --10.03M | --0 | --0 | --149K | --9.88M |
Depreciation and amortization | -0.14%103.71M | -1.33%24.38M | -3.75%25.53M | 1.09%26.77M | 3.40%27.03M | -3.61%103.86M | -2.36%24.71M | 7.55%26.52M | -9.28%26.48M | -8.57%26.14M |
Deferred tax | 298.45%12.05M | 72.19%-556K | 547.49%8M | 127.24%1.39M | -63.86%3.22M | 104.83%3.03M | 85.31%-2M | 110.40%1.24M | 68.87%-5.11M | 142.81%8.9M |
Other non cash items | -1.78%3.03M | 25.00%845K | -12.21%762K | -14.23%711K | 0.00%712K | 133.84%3.09M | -62.28%676K | 130.85%868K | 109.12%829K | 132.39%712K |
Change In working capital | 885.41%30.39M | 2.64%7.65M | 21,072.46%29.22M | 116.64%597K | -671.94%-7.07M | 160.91%3.08M | 206.92%7.45M | -91.14%138K | -171.21%-3.59M | 88.32%-916K |
-Change in receivables | 176.94%3.07M | 838.46%8.17M | 39.85%-1.8M | -2.78%664K | -56.12%-3.97M | -672.70%-3.99M | -7.54%871K | -43.91%-3M | -76.56%683K | -136.15%-2.54M |
-Change in prepaid assets | -164.88%-1.91M | -78.29%-2.18M | 186.93%592K | -77.52%207K | -113.26%-520K | 150.74%2.94M | 55.13%-1.23M | 63.85%-681K | 213.70%921K | 1,183.15%3.92M |
-Change in payables and accrued expense | 696.43%29.48M | -53.08%3.38M | 956.92%30.15M | 81.92%-750K | -50.34%-3.3M | 4.31%3.7M | 153.54%7.19M | -36.46%2.85M | -307.30%-4.15M | 61.99%-2.2M |
-Change in other current assets | -334.86%-3.12M | -55.06%422K | -2,056.62%-5.91M | 255.19%284K | 671.85%2.08M | 103.37%1.33M | 1.19%939K | -45.29%302K | -225.34%-183K | 127.75%270K |
-Change in other current liabilities | 420.78%2.87M | -550.76%-2.14M | 832.88%6.19M | 122.33%192K | -269.92%-1.37M | -143.22%-895K | -173.11%-329K | 36.98%663K | -209.41%-860K | -205.13%-369K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 44.85%150.09M | -1.75%34.25M | 114.75%60.06M | 55.26%30.98M | 19.06%24.8M | 39.60%103.61M | 59.69%34.86M | 10.40%27.97M | 49.95%19.95M | 51.45%20.83M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -86.20%-44.85M | 59.46%-10.79M | 19.86%-11.24M | -15.35%-11.69M | -141.69%-11.13M | 39.08%-24.09M | -149.12%-26.62M | -14.91%-14.03M | -11.58%-10.14M | 452.82%26.69M |
Capital expenditure reported | 12.42%-43.86M | 21.03%-10.59M | 15.67%-11.03M | -7.77%-11.21M | 16.35%-11.04M | -48.99%-50.08M | -81.57%-13.41M | ---13.08M | ---10.4M | ---13.2M |
Net PPE purchase and sale | -34.92%-989K | -162.92%-207K | 77.74%-211K | -216.91%-484K | 83.52%-87K | 76.92%-733K | 159.49%329K | -18.65%-948K | 132.57%414K | 4.52%-528K |
Net intangibles purchase and sale | --0 | ---- | ---- | ---- | ---- | -392.55%-13.55M | ---- | ---- | ---- | ---- |
Net business purchase and sale | --0 | --0 | --0 | --0 | --0 | --40.27M | --0 | --0 | ---150K | --40.42M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -86.20%-44.85M | 59.46%-10.79M | 19.86%-11.24M | -15.35%-11.69M | -141.69%-11.13M | 39.08%-24.09M | -149.12%-26.62M | -14.91%-14.03M | -11.58%-10.14M | 452.82%26.69M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 56.22%-12.67M | 63.46%-2.01M | -1,509.96%-7.6M | 88.71%-82K | 86.58%-2.99M | -65.78%-28.94M | -27.37%-5.49M | 92.04%-472K | 86.86%-726K | -1,210.90%-22.26M |
Net issuance payments of debt | 511.75%82.35M | --0 | --82.35M | --0 | --0 | ---20M | --0 | --0 | --0 | ---20M |
Net common stock issuance | -1,543.24%-41.54M | 101.42%36K | ---- | ---- | ---- | 74.72%-2.53M | 20.23%-2.53M | ---- | ---- | ---- |
Cash dividends paid | 33.36%-2.35M | 8.88%-2.35M | --0 | --0 | --0 | -270.66%-3.53M | -456.80%-2.58M | -231.37%-338K | -43.78%-555K | ---54K |
Proceeds from stock option exercised by employees | --395K | --0 | ---- | ---- | -99.75%-2.41M | --0 | --0 | ---- | ---- | 29.03%-1.21M |
Net other financing activities | -1,682.36%-51.53M | 180.84%308K | -36,293.28%-48.77M | -80.89%-2.49M | 42.00%-580K | 55.58%-2.89M | 85.66%-381K | ---134K | ---1.38M | ---1M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 56.22%-12.67M | 63.46%-2.01M | -1,509.96%-7.6M | 88.71%-82K | 86.58%-2.99M | -65.78%-28.94M | -27.37%-5.49M | 92.04%-472K | 86.86%-726K | -1,210.90%-22.26M |
Net cash flow | ||||||||||
Beginning cash position | 54.06%144.15M | 52.24%215.26M | 36.05%174.04M | 30.30%154.83M | 54.06%144.15M | 22.56%93.56M | 63.03%141.39M | 60.85%127.92M | 47.01%118.83M | 22.56%93.56M |
Current changes in cash | 83.00%92.56M | 678.73%21.45M | 206.03%41.22M | 111.24%19.21M | -57.71%10.69M | 193.69%50.58M | -59.70%2.76M | 87.15%13.47M | 798.85%9.09M | 462.72%25.27M |
End cash Position | 64.22%236.71M | 64.22%236.71M | 52.24%215.26M | 36.05%174.04M | 30.30%154.83M | 54.06%144.15M | 54.06%144.15M | 63.03%141.39M | 60.85%127.92M | 47.01%118.83M |
Free cash flow | 168.10%105.24M | 184.63%23.46M | 250.18%48.82M | 93.50%19.29M | 92.51%13.67M | 13.18%39.25M | -26.05%8.24M | 6.21%13.94M | 136.04%9.97M | 14.77%7.1M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |